drugset / Trial / NCT00772980

Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus

NCT00772980 ↗

Phase 3 Completed 400 enrolled Merz Pharmaceuticals GmbH
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to investigate the safety and efficacy of neramexane mesylate in the treatment of subjective tinnitus in comparison to placebo.

Timeline

Start
2008-11
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Neramexane Small molecule 75 mg —

Indications